Cardiovascular Disease
Showing NaN - NaN of 29
Ketogenic Diets on Cardiovascular Health in Adults With Epilepsy
Enrolling by invitation
- Hypercholesterolemia
- +7 more
- Modified Atkins or Ketogenic Diet
-
Baltimore, MarylandJohns Hopkins University
Jan 6, 2023
Patients With Heart Failure Using HeartLogic
Completed
- Heart Failure
- +5 more
- HeartLogic Sensors
-
Birmingham, Alabama
- +87 more
Oct 24, 2022
Healthy Aging in Neighborhoods of Diversity Across Life Span
Active, not recruiting
- Diabetes
- +3 more
-
Baltimore, MarylandNational Institute of Aging, Clinical Research Unit
Aug 24, 2022
Cardiovascular Disease, Hypertension, Care Coordination Trial in United States (Intervention group, Education control group)
Recruiting
- Cardiovascular Disease
- +3 more
- Intervention group
- Education control group
-
Decatur, Georgia
- +3 more
Jul 29, 2022
Aging, Exercise, Cardiovascular Disease Trial in Baltimore (Exercise Training, Exercise Cessation)
Active, not recruiting
- Aging
- +2 more
- Exercise Training
- Exercise Cessation
-
Baltimore, MarylandUniversity of Maryland, Baltimore & Baltimore VA Medical Center
Feb 28, 2022
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
Elevated Lipoprotein(a), Cardiovascular Disease Trial in Worldwide (ISIS 681257, Placebo)
Completed
- Elevated Lipoprotein(a)
- Cardiovascular Disease
- ISIS 681257
- Placebo
-
Cottonwood, Arizona
- +31 more
Oct 26, 2020
Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)
Vascular Aging: The Link That Bridges Age to Atherosclerosis
Terminated
- Atherosclerosis
- +2 more
-
Baltimore, Maryland
- +1 more
Dec 6, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1595 more
Apr 18, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1745 more
Jun 14, 2018
Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)
Completed
- Cardiovascular Disease
-
Decatur, Georgia
- +202 more
Jun 12, 2018
Atherosclerosis, Cardiovascular Disease Trial in Baltimore (any statin, niacin, Placebo)
Completed
- Atherosclerosis
- Cardiovascular Disease
- any statin
- +2 more
-
Baltimore, MarylandJohns Hopkins Unversity School of Medicine
Oct 4, 2017
Chronic Kidney Disease, Cardiovascular Disease, Death Trial in Brazil, Canada, United States (High Dose Multivitamin, Low Dose
Completed
- Chronic Kidney Disease
- +2 more
- High Dose Multivitamin
- Low Dose Multivitamin
-
Birmingham, Alabama
- +29 more
Sep 17, 2017
Cardiovascular Disease Trial in Worldwide (EVARREST™ Fibrin Sealant Patch, Topical hemostat)
Completed
- Cardiovascular Disease
- EVARREST™ Fibrin Sealant Patch
- Topical hemostat
-
Atlanta, Georgia
- +23 more
Aug 14, 2017
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)
Terminated
- Type 2 Diabetes
- Cardiovascular Disease
- TAK-875
- TAK-875 Placebo
-
Birmingham, Alabama
- +587 more
Oct 15, 2015
Diabetes, Cardiovascular Disease, Substance Abuse Disorder Trial in Baltimore (Co-developed IT intervention)
Unknown status
- Diabetes
- +3 more
- Co-developed IT intervention
-
Baltimore, MarylandZip codes surrounding Johns Hopkins Hospital
Aug 20, 2014
Physician Utilization of Shock Reduction Programming
Completed
- Cardiovascular Disease
- Therapy Programming Report (TPR)
-
Anniston, Alabama
- +103 more
Jul 1, 2014
Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (Aliskiren, Placebo)
Terminated
- Type 2 Diabetes Mellitus
- Cardiovascular Disease
- Aliskiren
- Placebo
-
Birmingham, Alabama
- +777 more
Apr 1, 2014
Cardiovascular Disease, Stable Angina, Myocardial Infarction Trial in Baltimore (ticagrelor)
Unknown status
- Cardiovascular Disease
- +3 more
-
Baltimore, MarylandSinai Center for Thrombosis Research
Dec 10, 2013
Type 2 Diabetes, Cardiovascular Disease, Hypertension Trial in Worldwide (Dapagliflozin, Placebo)
Completed
- Type 2 Diabetes Mellitus
- +3 more
- Dapagliflozin
- Placebo
-
Gulf Shores, Alabama
- +140 more
Sep 24, 2013
Cardiovascular Disease, Obstructive Sleep Apnea, Coronary Artery Disease Trial in Baltimore, Boston, Cleveland (Healthy
Completed
- Cardiovascular Disease
- +2 more
- Healthy Lifestyles and Sleep Education plus PAP
- +2 more
-
Baltimore, Maryland
- +3 more
Feb 21, 2013
Cardiovascular Disease Trial in Baltimore (Placebo, Doxycycline)
Withdrawn
- Cardiovascular Disease
- Placebo
- Doxycycline
-
Baltimore, MarylandJohns Hopkins University SOM. 1830 East Monument St, Ste 7500
Mar 29, 2012